| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2878284 | The Annals of Thoracic Surgery | 2010 | 6 Pages |
Abstract
In this first large-scale human experience, LeGoo had been an atraumatic, safe, and effective temporary coronary artery occluder. It produced a bloodless field during OPCABG in 91% of target vessels. Improvements on these results with further experience is anticipated.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Olivier MD, Robert L. MD, Jean Pierre MD, François MD, Roger MD,